This Pearl is provided as free content subject to our terms and conditions click here
Cancer: presenting symptoms of children with cancer
Cancer: presenting symptoms of children with cancer
This article was reviewed in April 2024.
You may also find the article Brain tumours in adults and children useful.
Childhood cancer
- In the UK, 1 in 320 children (yes, really!) will have developed malignant disease by the time they are 20. This number is 1 in 450 by the age of 15 (BJGP 2021;71:151).
- A general practice will see a child or young person with cancer every 1.8 years.
- An average GP will see 1 childhood cancer in a 5–10-year period.
It is something we worry about missing, and, like so many diseases, the textbook descriptions of the presentations of childhood cancer are based on how children present to hospital, rather than to primary care.
- Leukaemia is the most common childhood cancer in the UK (31% of cases) (NHS Digital, NDRS 2021).
- CNS tumours are the second most common (26%).
- The majority of childhood cancer cases are solid tumours (so, statistically, ‘on average’, we are more likely to encounter one of these).
A Danish population cohort study looked at all children in Denmark aged <15y diagnosed with cancer and low-grade brain tumours between 2007 and 2010. It sent GPs surveys to gather information on symptoms and the diagnostic process (BJGP 2012;62:352).
- At first consultation, most children had only a few symptoms and these were non-specific (pain, swelling/lump and weakness).
- Only 20% of symptoms were reported as alarming at first consultation.
Finding cancer in children and young people
Clinical symptoms and signs
The Grace Kelly Trust has summarised the NICE guidance in a mnemonic and pictogram, and we find this a little easier to remember than the NICE lists. We have reproduced the Grace Kelly information (with permission) below.
- C oncern.
- A norexia.
- N umber of attendances (3).
- C omplexion (pale).
- E xhaustion.
- R ecurrent pyrexia.
Reproduced with kind permission of the Grace Kelly Childhood Cancer Trust.
NICE gives us guidance on organ-specific presentations:
NICE on cancer in children and young people (NICE 2015, NG12) | ||
Site | Symptom/sign | Action |
Brain and CNS | Newly abnormal cerebellar or other central neurological function. | Very urgent referral: appointment within 48h. |
Haematological | Unexplained petechiae or hepatosplenomegaly. | Immediate specialist assessment. |
Haematological: leukaemia | Any of the following: | Very urgent full blood count (<48h). |
Haematological: lymphoma | Unexplained lymphadenopathy or splenomegaly. Also consider if: | Very urgent referral: appointment within 48h. |
Sarcoma | Unexplained bone swelling or pain. | Very urgent (<48h) X-ray. |
Unexplained lump that is increasing in size. | Very urgent (<48h) ultrasound. | |
X-ray or ultrasound suggests sarcoma. | Very urgent referral: appointment within 48h | |
Neuroblastoma or Wilm’s tumour | Palpable abdominal mass or unexplained enlarged abdominal organs. | Very urgent referral: appointment within 48h. |
Wilm’s tumour | Unexplained visible haematuria. | Very urgent referral: appointment within 48h. |
Retinoblastoma | Absent red reflex. | Consider urgent ophthalmology referral. |
Loss of red reflex occurs with new-onset squint. | Refer immediately. | |
Non-site-specific symptoms |
Gut instinct
Two BJGP editorials have some useful pointers (BJGP 2021;71:e356 and BJGP 2021;71:151):
- Gut feelings are based on a fusion of medical knowledge and experience, and influence our decisions. They may prompt further action in the absence of frank red flag symptoms, and should not be ignored.
Frequent attendance
There are 12 key symptoms which raise the prior probability of childhood cancer by 10 times, although a benign cause for each symptom (except an abdominal mass) remains much more likely than cancer (BJGP 2013;63:e22). These 12 symptoms are included in the Grace Kelly summary image/NICE guidance.
If a child presents for the third time in 3 months, for any reason, with any of these 12 key symptoms, the risk of cancer increases further.
Parental concern
NICE and the Grace Kelly Childhood Cancer Trust remind us to consider referral for suspected cancer in a child or young person if their parent or carer has persistent concern or anxiety about the child's symptoms (NICE 2015, NG12).
Ewing’s sarcoma
Although not specifically mentioned in the NICE guidance, this may be an opportunity to remind ourselves about Ewing’s sarcoma:
- An aggressive bone and soft tissue cancer of children and young adults.
- 10 times more common in those of European than African ancestry.
- It accounts for 2% of childhood cancers, with peak age at diagnosis of 15 years.
- 80% arise in bone, but 20% are extra-osseous.
Ewing’s sarcoma presents with localised pain and swelling, and initially may be mistaken for a minor injury. Pain is worse at night (big red flag!) and after exercise. Pathological fracture is present in 10–15% of cases, and constitutional symptoms may occur (weight loss, night sweats, fever, fatigue).
X-ray shows a ‘motheaten’ appearance in bone. Blood test may show raised lactase dehydrogenase, but raised alkaline phosphatase is non-specific. Treatment is multimodal, and prognosis has improved dramatically in recent years due to new therapeutic options (NEJM 2021;384:154).
Cancer: presenting symptoms of childhood cancer | |
Useful resources: Websites (all resources are hyperlinked for ease of use in Red Whale Knowledge) |
Related content
This information is for use by clinicians for individual educational purposes, and should be used only within the context of the scope of your personal practice. It should not be shared or used for commercial purposes. If you wish to use our content for group or commercial purposes, you must contact us at sales@red-whale.co.uk to discuss licensing, otherwise you may be infringing our intellectual property rights.
Although we make reasonable efforts to update and check the information in our content is accurate at the date of publication or presentation, we make no representations, warranties or guarantees, whether express or implied, that the information in our products is accurate, complete or up to date.
This content is, of necessity, of a brief and general nature, and this should not replace your own good clinical judgment or be regarded as a substitute for taking professional advice in appropriate circumstances. In particular, check drug doses, side effects and interactions with the British National Formulary. Save insofar as any such liability cannot be excluded at law, we do not accept any liability for loss of any type caused by reliance on the information in these pages.
For access to our full terms and conditions click here